Home > Insider Trading > Filing (0001179110-17-015442)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1005201	Depomed Inc	DEPO	Pharmaceutical Preparations (2834)	943229046

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1142083	J Arthur Higgins	C/O Depomed Inc. 7999 Gateway Boulevard, Suite 300 Newark CA 94560	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-12-14	75,000	$8.16	111,760	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Acquisiton	2017-12-14	73,529	$0.00	73,529	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
73,529		2027-12-14	No	4	A	Direct

Footnotes

Amount excludes 1,000 shares of common stock held indirectly by Child but includes 15,000 shares held indirectly by Family Trust.
Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
These restricted stock units are scheduled to fully vest on December 5, 2020, assuming continued employment through the applicable vesting date.
These Restricted Stock Units were granted pursuant to the one-time incentive program for the Company's Chief Executive Officer which was approved by the Board on December 6, 2017.